Related Experiment Video
Updated: May 5, 2026

A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence
Published on: March 23, 2022
Exploring Medication Safety in Transitions From Prison to Community: A Qualitative Study
Claire Planner1,2, Richard N Keers2,3,4, Denham Phipps3
1NIHR School for Primary Care Research, Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Improving medication safety during prison transitions requires addressing release practices, communication, and staffing. Solutions include electronic prescribing and better care coordination to prevent harm.
Area of Science:
- Healthcare delivery research
- Patient safety
- Medication management
Background:
- High turnover in England and Wales prisons (47% <12 months) creates risks during community transitions.
- Medication-related harm is a significant concern due to complex health needs and fragmented systems.
- Current guidance implementation for safe medication management during transitions is inconsistent.
Purpose of the Study:
- To explore factors influencing medication safety during prison-to-community transitions.
- To identify human, organizational, and environmental influences on medication safety.
- To gather staff perspectives on potential solutions for improving medication safety.
Main Methods:
- Qualitative study using semi-structured interviews with 12 staff (GPs, pharmacists, prison officers).
- Participants recruited via professional networks and snowball sampling.
- Thematic analysis employed using the Systems Engineering Initiative for Patient Safety (SEIPS) framework.
Main Results:
- Identified five key factors: release practices, care coordination, staffing, IT systems, and patient factors.
- Risks include immediate releases, medication regimen discontinuity, and poor information transfer.
- Staff proposed solutions: electronic prescribing, improved information sharing, dedicated discharge teams, early planning, and multidisciplinary meetings.
Conclusions:
- Medication safety during prison transitions necessitates addressing organizational issues like short-notice releases and information transfer.
- Human factors, including communication barriers and staffing, are critical.
- Enhancing roles, processes, technology, and collaboration is vital for continuity of care and safety.
More Related Videos
08:53Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
Published on: May 31, 2019
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Drug Dosing: Geriatric Patients
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Therapy
Antianxiety Medications
The Stanford Prison Experiment